Incubation of lysate from human polymorphonucleated neutrophils and human platelets with r3'P]NAD resulted in the labeling of a 42-kDa protein. Phosphodiesterase (Crotalus durissus) released 5'-AMP from the radiolabeled protein. The 42-kDa protein was identified as actin by binding to DNAse-I, two-dimensional gel electrophoresis and partial proteolysis. The rate of ADP-ribosylation was greater with [32P]ADP-ribose than with [32P]NAD, indicating a non-enzymic modification. ADP-ribose also modified actin in the actin-DNAse-I complex, but denatured actin was not modified by ADP-ribose. Only cytoplasmic Ply-actin isoforms were non-enzymically ADP-ribosylated but not muscle a-actin. The acceptor amino acid was identified as a cysteine residue whereas the bacterial ADP-ribosyltransferase C. perfringens iota toxin catalyzes incorporation of ADP-ribose to Arg177 of actin. Alkylation of cysteine residues of actin with N-ethylmaleimide prevented subsequent non-enzymic ADP-ribosylation but not the toxin catalyzed modification. Non-enzymically ADP-ribosylated actin was further modified by C. pe$ringens iota toxin. The F-actin stabilizing mycotoxin phalloidin blocked the non-enzymic ADP-ribosylation and, conversely, ADP-ribosylation inhibited the phalloidin-induced polymerization of ADP-ribosylated actin. The data indicate that cytoplasmic actin is non-enzymically ADP-ribosylated by ADP-ribose at a cysteine residue to inhibit actin polymerization.Actin is one of the most abundant proteins in eukaryotic cells. Besides its important role in the organization of cell architecture (for review, see [l]), actin is involved in various cellular motile functions such as locomotion, cytoplasmic streaming, endocytosis and exocytosis 12-51. Actin is the substrate for several ADP-ribosylating bacterial toxins 16-81. The family of actin-modifying toxins comprises Clostridium botulinum C2 toxin [9], Clostridium perjringens iota toxin [lo, 111, Clostridium spiroforme toxin 112, 131 and an ADP-ribosyltransferase produced by Clostridium difficile 1141 (for review, see [8, 151). Using protein chemistry [16, 171 and site-directed mutagenesis 1181, it has been demonstrated that these toxins mono-ADP-ribosylate actin at Arg177. The toxin-catalyzed ADP-ribosylation grossly alters the biochemical and physiological functions of actin: Firstly, ADP-ribosylation inhibits the ability of actin to polymerize [ 10, 191. Secondly, ADP-ribosylated actin interacts with the fast growing, barbed ends of actin filaments in a manner similar to that of a capping protein and inhibits the polymerization of non-modified actin 120, 211. Thirdly, ADP-ribosylation inhibits monomeric G-actin ATPase activity [22, 231. Furthermore, recent studies indicate that the toxins ADP-ribosylate actin complexed with gelsolin, thereby altering the nucleation activity of the gelsolin-actin complex [24]. In intact cells, the pathophysiological effects of the toxin-cataCorrespondence to I. Just, lnstitut fur Pharmakologie und Toxikologie der Universitat des Saarlandes, D-66421 Homburg-S...